Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2018 | 12-2017 | 12-2016 | 12-2015 | 12-2014 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 2,391,050 | 2,863,619 | 2,777,334 | 2,518,142 | 2,566,807 |
| Marketable Securities | 31,192 | 349,978 | 377,147 | 572,285 | 274,404 |
| Receivables | 4,111,328 | 3,577,397 | 3,595,674 | 3,216,014 | 3,387,878 |
| Inventories | 2,497,774 | 2,335,159 | 2,131,073 | 1,898,390 | 2,024,953 |
| Other current assets | 1 | -1 | 0 | 1 | 0 |
| TOTAL | $9,031,345 | $9,126,152 | $8,881,228 | $8,204,832 | $8,254,042 |
| Non-Current Assets | |||||
| PPE Net | 6,405,134 | 5,354,020 | 4,484,600 | 3,801,096 | 4,125,149 |
| Investments And Advances | 271,092 | 267,648 | 326,474 | 319,920 | 152,625 |
| Intangibles | 786,671 | 505,068 | 403,300 | 321,110 | 245,697 |
| Other Non-Current Assets | 442,340 | 294,838 | 398,693 | 1,012,733 | 962,642 |
| TOTAL | $7,905,236 | $6,421,573 | $5,613,068 | $5,454,859 | $5,486,113 |
| Total Assets | $16,936,580 | $15,547,720 | $14,494,290 | $13,659,690 | $13,740,150 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 78,744 | 257,319 | 34,029 | 159,662 | 128,376 |
| Accounts payable and accrued liabilities | 1,032,992 | 852,159 | 893,235 | 733,138 | 882,585 |
| Other current liabilities | 6,465,071 | 5,393,969 | 5,530,892 | 4,627,085 | 4,501,718 |
| TOTAL | $8,281,676 | $7,147,807 | $7,048,990 | $6,081,902 | $6,006,749 |
| Non-Current Liabilities | |||||
| aiOther Non-Current Liabilities | 710,679 | 704,512 | 716,401 | 587,909 | 547,738 |
| TOTAL | $728,721 | $833,020 | $718,332 | $588,802 | $548,986 |
| Total Liabilities | $9,010,397 | $7,980,826 | $7,767,322 | $6,670,704 | $6,555,734 |
| Shareholders' Equity | |||||
| Common Shares | 74,921 | 75,950 | 75,786 | 77,376 | 94,499 |
| Retained earnings | 8,165,777 | 7,439,606 | 6,852,095 | 6,966,221 | 7,359,689 |
| Other shareholders' equity | -312,515 | 53,342 | -199,907 | -53,610 | -267,768 |
| TOTAL | $7,926,183 | $7,566,898 | $6,726,974 | $6,988,987 | $7,184,420 |
| Total Liabilities And Equity | $16,936,580 | $15,547,724 | $14,494,296 | $13,659,691 | $13,740,154 |